Family Health Team High-Intensity Interval Training

Not Applicable

Recruiting

• Conditions: Type 2 Diabetes

• Registration Number: NCT04109235
• Lead Sponsor: Western University, Canada

Brief Summary

With the rapid shift to virtual care, this pilot study aims to determine the feasibility of prescribing low-duration, interval-based training through virtual care. If successful, this study will inform a larger randomized control trial to determine if the prescription of low-duration interval-based training improves chronic disease through the measurement of hemoglobin A1C (HbA1C), and weight to a greater extent than the general guideline to aim for 150 minutes of PA weekly.

Detailed Description

Dr. Fernando will invite patients to participate in this trial during their virtual diabetes appointments at the East Elgin Family Health Team (EEFHT). Participants will be randomized 1:1 using computer-generated randomization software to receive either a population-based, standard activity intervention (control group) or a high-intensity interval training (HIIT) intervention, which they will complete on their own time, at the location of their choosing (at home, gym, outside, or elsewhere). Data will be collected at baseline (T1), and participants will be followed up after 3 months (T2) and 6 months (T3). All data acquisition is from standard of care (i.e. patients are already seen every 3 months for diabetes visits). Data collection at T1, T2 and T3 will include:

* Weight and Height (measured using the Health-O-Meter weigh scale, used to calculate BMI)

* Minutes of PA (self-reported by participants using the log books designed for this study)

* HbA1C (requisition will be provided by Dr. Fernando. Patients will be exempt from completing the baseline HbA1C if they have had a HbA1C measurement in the past 30 days \& the patient has not made significant lifestyle changes or had any blood glucose medications changed; in this case, the measurement completed in the past 30 days will be used as the baseline measure)

* Blood glucose and blood pressure medications

Study Timeline

• Study First Submitted: 2019-09-12
• Study First Submitted QC: 2019-09-27
• Study First Posted: 2019-09-30
• Study Start: 2020-02-13
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-07
• Last Update Posted: 2024-03-12
• Primary Completion: 2026-07-13
• Study Completion: 2026-07-13

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• adults, at least 18 years of age
• non-pregnant
• having a diagnosis of type 2 diabetes in accordance with the 2018 Diabetes Canada Clinical Practice Guidelines
• capable of consenting
• deemed capable and safe to exercise by their physician (Dr. Fernando)
• without a medical history of myocardial infarction in the past three months.

Exclusion Criteria

• < 18 years of age
• pregnant
• not having a type 2 diabetes diagnosis
• having a medical history of myocardial infarction in the past 3 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in HbA1C	3-month and 6-month follow-up	Glycosylated Hemoglobin measured at lab

Secondary Outcome Measures

Name	Time	Method
Weight	3-month and 6-month follow-up	self-reported by participants using home scale
Physical Activity (minutes per week)	3-month and 6-month follow-up	self-reported by participants using the log books designed for this study

Trial Locations

Locations (1)

East Elgin Family Health Team; 🇨🇦 Aylmer, Ontario, Canada